Safety monitoring
coronary artery injury, arrhythmia
PULMONARY EMBOLISM, ARRHYTHMIA
For monitoring the safety of treatment, a cardiologist visited the patients daily during hospitalization. A physical examination was conducted, and vital signs were noted. The patients were monitored for indicators of arrhythmia, pulmonary embolism, and coronary artery injury. Baseline tests including fasting blood sugar (FBS), complete cell blood count (CBC), urea and electrolytes, liver function tests (LFTs), creatine kinase, and cardiac troponin T and C reactive protein were also requested. A standard 12-lead electrocardiogram (ECG) and echocardiography were also taken. Safety measure was monitored using a standard questionnaire presented in Additional file 